Decreased Risk of Depression in Patients With Psoriasis Treated With Biologics Versus Conventional Therapy: A Retrospective Cohort Analysis Using <scp>TriNetX</scp>
S.R.L. has served as a consultant for Moberg Pharmaceuticals and BelleTorus Corporation. J.M.C. serves on a data and safety monitoring board for Advarra and has served as a consultant for Novartis, Takeda, GSK, and Sanofi. Data for this study was obtained from the TriNetX database and is available at https://trinetx.com/ with the permission of the TriNetX database authority.
Authors
- Shari R. Lipner (ORCID: https://orcid.org/0000-0001-5913-9304)
- Jeffrey M. Cohen (ORCID: https://orcid.org/0000-0002-7709-0548)
- Naeha Pathak (ORCID: https://orcid.org/0000-0002-9870-0704)
- Weston P. Lowry (ORCID: https://orcid.org/0009-0000-2935-4900)
Institutions
- Cornell University (US)
- Yale University (US)
- Weill Cornell Medicine (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1111/ijd.70117
- Primary Topic
- Health, psychology, and well-being
- Type
- article
- Field-Weighted Citation Impact
- 0.00